• OPEN AN ACCOUNT
Indian Indices
Sensex
78,460.21 -178.82
( -0.23%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,705.00 -657.02
(-1.02%)
Nikkei 225
10,850.37 -17.68
(-0.16%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

Mankind Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543904
INE634S01028
397.024678
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MANKIND
45.19
102193.79
EPS(TTM)
Face Value()
Div & Yield %
54.76
1
0.04
 

BNR Udyog reports standalone net loss of Rs 0.49 crore in the March 2026 quarter
May 22,2026
Net Loss of BNR Udyog reported to Rs 0.49 crore in the quarter ended March 2026 as against net loss of Rs 0.37 crore during the previous quarter ended March 2025. Sales reported to Rs 0.09 crore in the quarter ended March 2026 as against Rs -0.07 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.53 crore in the year ended March 2026 as against net loss of Rs 0.55 crore during the previous year ended March 2025. Sales declined 13.55% to Rs 1.34 crore in the year ended March 2026 as against Rs 1.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.09-0.07 LP 1.341.55 -14
OPM %-877.781200.00 --77.61-64.52 -
PBDT-0.75-0.79 5 -0.70-0.88 20
PBT-0.79-0.82 4 -0.83-1.00 17
NP-0.49-0.37 -32 -0.53-0.55 4